4-Methylumbelliferone Targets Revealed by Public Data Analysis and Liver Transcriptome Sequencing
Sign Up to like & getrecommendations! Published in 2023 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms24032129
Abstract: 4-methylumbelliferone (4MU) is a well-known hyaluronic acid synthesis inhibitor and an approved drug for the treatment of cholestasis. In animal models, 4MU decreases inflammation, reduces fibrosis, and lowers body weight, serum cholesterol, and insulin resistance.… read more here.
Keywords: public data; targets revealed; analysis; liver transcriptome ... See more keywords